Bleeding complications following percutaneous coronary interventions (PCI) have been closely associated with morbidity and mortality. Although radial arteries have been widely used in current PCI, including primary PCI, transfemoral PCI remains necessary for complex PCI. The purpose of this study was to compare the incidence of complications following elective transfemoral PCI between manual compression with and without protamine. We identified 249 consecutive patients who underwent elective transfemoral PCI from hospital records, and divided them into two groups: patients who used protamine for manual compression (the protamine group; n = 205) and patients who did not (the non-protamine group, n = 44). Complications including acute thrombosis, bleeding requiring blood transfusion, transient hypotension, skin rash, and death within 30 days were compared between groups. The baseline clinical and procedural characteristics were comparable between the protamine and non-protamine groups. The incidences of all complications were not different between the protamine (5.9%) and the non-protamine groups (9.1%) (P = 0.43). While more than 90% of the patients received drugeluting stent implantation, there was no acute thrombus in either group. The incidence of bleeding requiring blood transfusion was significantly lower in the protamine group (0.5%) than in the non-protamine group (6.8%) (P = 0.002). Multivariate logistic regression analysis revealed the inverse association between protamine use and bleeding requiring blood transfusion (odds ratio 0.08, 95% confidence interval 0.01-0.84, P = 0.04). In conclusion, the use of protamine for manual compression following elective transfemoral PCI was safe and was associated with less bleeding complications.
B
leeding complications following percutaneous coronary interventions (PCI) have been closely associated with morbidity and mortality. [1] [2] [3] The access site is an important determinant of bleeding complications following PCI, 4) and the incidence of bleeding complications is significantly lower in transradial PCI than in transfemoral PCI. 5) Although radial arteries have been widely used in current PCI, including primary PCI, 6) transfemoral PCI remains necessary for complex PCI requiring a !7 Fr guide system such as chronic total occlusion or severely calcified lesions. 7, 8) Therefore, it would be of utmost importance to obtain definite hemostasis following sheath removal from the femoral artery.
Arterial closure devices such as Perclose Proglide or Angio-Seal were shown to achieve earlier hemostasis and shorter ambulation as compared to manual compression. 9) However, there was no significant difference in major vascular complications between the use of arterial closure devices and manual compression. 9, 10) Severe complications including pseudoaneurysm, retroperitoneal hematoma, infection, distal ischemia, and death were reported in the use of arterial closure devices. 10) Furthermore, these devices are not applicable to calcified or stenotic femoral arteries (< 6 mm). 9) Therefore, manual compression is still required for a substantial proportion of transfemoral PCIs, although it may require being performed several hours before sheath removal because of the prolonged activated coagulation time (ACT). Protamine can reverse the prolonged ACT, but has not been widely used after PCI, probably due to concerns regarding side effects such as anaphylactic reactions to protamine or acute stent closure. We hypothesized that the use of protamine for manual compression just after transfemoral PCI would be a safe strategy. The purpose of this study was to compare the incidence of complications following elective transfemoral PCI between manual compression with and without protamine.
SAFETY OF REVERSING ANTICOAGULATION

Methods
We selected consecutive patients who underwent transfemoral PCI from April 2010 to December 2013 from hospital records in Saitama Medical Center, Jichi Medical University. The exclusion criteria were 1) emergent PCI to the culprit lesion of acute coronary syndrome, 2) use of arterial closure devices such as Perclose Proglide (Abbott Vascular, Abbott Park, IL, USA), 3) cases to whom dual antiplatelet therapy (DAPT) was not administered before PCI, and 4) cases for which the hospital records were unclear regarding protamine use. Also, in patients who underwent multiple PCI during the study period, only the first procedure was analyzed. We divided our study population into patients to whom protamine was administered (the protamine group) and patients who did not (the non-protamine group). Complications including acute thrombosis, bleeding requiring blood transfusion, transient hypotension, skin rash, and death within 30 days were compared between the protamine and non-protamine groups. This study was approved by the institutional review board and written informed consent was waived because of the retrospective study design.
Acute thrombosis was defined as acute stent thrombosis 11) or acute vessel closure within 24 hours following PCI. 12) Transient hypotension was defined as 20 mmHg decrease in the systolic blood pressure. Hypertension was defined as systolic blood pressure > 140 mmHg, diastolic blood pressure > 90 mmHg, or medical treatment for hypertension. Diabetes mellitus was defined as HbA1c (NGSP) value !6.4% or treatment for diabetes mellitus. Dyslipidemia was defined as triglyceride level !150 mg/ dL, low-density lipoprotein cholesterol level !140 mg/dL, high-density lipoprotein cholesterol < 40 mg/dL, or statin treatment. Chronic kidney disease was defined as an estimated glomerular filtration rate < 60 mL/minute/1.73 m 2 . PCI was performed using standard techniques. The choice of stent type and devices was left to the discretion of each interventional cardiologist. All patients who were included in the present study had DAPT at the time of the elective PCI. ACT was maintained at > 250 seconds during PCI. The use of protamine was also left to the discretion of the interventional cardiologist. In the protamine group, manual compression was mostly performed in the catheterization laboratory (n = 201) just after slow injection of 10 to 100 mg of protamine, and rarely in the medical ward (n = 4). Although our target ACT was < 200 seconds for manual compression, ACT was not routinely measured at the time of manual compression. In the non-protamine group, manual compression was performed in the catheterization laboratory (n = 14) just after the PCI or in the medical ward (n = 30) approximately 3 hours after PCI.
Manual compression required 20 to 30 minutes to achieve hemostasis in both groups. Non-invasive hemostasis devices such as Neptune pad (Biotronik, Berlin, Germany) or Algimelt (Kaneka, Osaka, Japan) were often used for manual compression in both groups. Both devices were sheets including alginate. After manual compression, all patients were ordered to take a strict bed rest for 3 hours and a non-strict bed rest for an additional 3 hours, which means a total of 6 hours bed rest. Statistical analysis: Data were expressed as mean ± SD or percentage. Categorical variables are presented as numbers (percentage) and compared with the Pearson's chisquared test. The Shapiro Wilk test was used to determine if the continuous variables were normally distributed. Normally distributed continuous variables were compared between the groups using an unpaired Student's t-test. Otherwise, continuous variables were compared using a Mann-Whitney U test. Multivariate logistic regression analysis was performed to investigate whether the incidence of bleeding requiring blood transfusion was lower in the protamine group than in the non-protamine group after controlling confounding factors. In this model, bleeding requiring blood transfusion was adopted as a dependent variable. The use of protamine and clinically proven risk factors for blood transfusion following PCI such as age, 13, 14) sex, 5, 15) body mass index, 14) sheath size, 16) hemoglobin, 14, 17) chronic renal failure on HD, 14, 18) and anticoagulation therapy 14) were used as independent variables. In multivariate logistic regression analysis, the backward stepwise (likelihood ratio) method was used because the number of events (bleeding requiring blood transfusion) was only four. The odds ratio (OR) and the 95% confidence interval (CI) were calculated. A P value < 0.05 was considered statistically significant. All analyses were performed using the SPSS statistical software, version 13 (SPSS, Chicago, IL, USA).
Results
A total of 854 patients received transfemoral PCI during the study period. We excluded 603 patients that did not meet the inclusion criteria. The present study population consisted of 249 patients, which was divided into the protamine group (n = 205) and the non-protamine group (n = 44). The study flow chart is shown in the Figure. The baseline clinical characteristics between the protamine non-protamine groups are shown in Table I . Most of the clinical characteristics were comparable between the groups except for body mass index and hemoglobin concentration, which were lower in the non-protamine group. The procedural characteristics between the groups are shown in Table II . Most of the clinical characteristics were comparable between the groups except diastolic blood pressure at the end of PCI, which was lower in the non-protamine group than in the protamine group. Drugeluting stent implantation was performed in more than 90% of the patients in the protamine group.
Complications following PCI between the groups are shown in Table III . The incidences of all complications were not different between the groups (P = 0.42). There was no acute thrombosis in either group. The incidence of bleeding that required blood transfusion was significantly lower in the protamine group (0.5%) than in the nonprotamine group (6.8%) (P = 0.002). Of the four cases who had bleeding requiring blood transfusion, three received blood transfusion due to bleeding from the puncture site and one case received blood transfusion due to multiple factors, including baseline anemia (Hb 10 mg/ dL), prolonged PCI procedure time, and bleeding from the puncture site. The details of those four cases are shown in Table IV . The incidences of transient hypotension and skin rash were not statistically different between the groups.
Multivariate logistic regression analysis to determine bleeding requiring blood transfusion is shown in Table V . The use of protamine was inversely associated with bleeding requiring blood transfusion after controlling confounding factors (vs. non-protamine: OR 0.08, 95% CI 0.01-0.84, P = 0.04).
Discussion
The present study included 249 patients who had manual compression for elective transfemoral PCI, and compared the incidence of complications between the protamine and non-protamine groups. Acute thrombosis was not observed in either group, while most patients underwent drug-eluting stent implantation. Although the incidences of all complications were not different between the groups, bleeding requiring blood transfusion was significantly lower in the protamine group. Furthermore, multivariate logistic regression analysis revealed the inverse association between the use of protamine and bleeding requiring blood transfusion after controlling confounding factors. These results suggest the safety and advantage of using protamine for manual compression following elective transfemoral PCI.
Protamine has been widely used as an antagonist for heparin, especially in the field of cardiovascular surgery, for decades. 19) Although heparin has been commonly used for PCI, the use of protamine was restricted in the field of PCI, probably due to concerns of side effects such as shock or anaphylaxis. Indeed, only a few studies investigated the safety of protamine use following PCI. Thuesen, et al. showed the safety of femoral sheath removal using protamine after PCI. 20) However, approximately a quarter of the patients had GPIIb/IIIa inhibitors, and DAPT was not started before PCI because of bare metal stent era. 20) Ducas, et al. also showed the safety of femoral sheath removal using protamine after PCI. 21) However, manual compression was only performed in one third of the study patients, and DAPT was not started before PCI because of bare metal stent era. 21) In our study, we included only patients who had already been administered DAPT at the time of PCI because most patients underwent drug-eluting stent implantation, which was not examined in earlier studies. Our results may suggest the safety of protamine use in the drug-eluting stent era. Furthermore, since GPIIb/IIIa inhibitors were not available in Japan, we did not include patients who had GPIIa/IIIa inhibitors. Our results suggest the safety of heparin reversal in patients who do not receive GPIIa/IIIa inhibitors, while our study only included elective PCI which would not require GPIIa/IIIa inhibitors.
Our results suggest not only the safety but also the advantage of protamine use given that the incidence of bleeding requiring blood transfusion was significantly lower in the protamine group. Since bleeding requiring blood transfusion after PCI is closely associated with mortality, 22, 23) it would be of utmost importance to prevent bleeding after PCI. Our multivariate logistic regression analysis included multiple clinical risk factors for bleeding after PCI such as age, 13, 14) sex, 5, 15) body mass index, 14) sheath size, 16) hemoglobin, 14, 17) chronic renal failure on HD, 14, 18) and anticoagulation therapy; 14) however, protamine use was only significantly associated with bleeding requiring blood transfusion in our multivariate analysis. Furthermore, only protamine use was a modifiable factor without sacrificing safety, while discontinuing anticoagulation or reducing sheath size would pose a potential risk for pa-SAFETY OF REVERSING ANTICOAGULATION Data were expressed as mean ± SD or numbers (percentages). The Student's t-test was used for normally distributed continuous variables, and Mann-Whitney U test was used for abnormally distributed continuous variables. The Pearson's chi-square test was used for categorical variables. PCI indicates percutaneous coronary intervention; LAD, left anterior descending artery; LM, left main; LCX, left circumflex artery; and RCA, right coronary artery. Hematoma from puncture site, baseline anemia Immediate PCI indicates percutaneous coronary intervention; IHD, ischemic heart disease; Hb, hemoglobin; CRF on HD, chronic renal failure on hemodialysis; and CCU, coronary care unit. The backward stepwise (likelihood ratio) method was used. Initial model included protamine use, age, male sex, body mass index, sheath size, hemoglobin, chronic renal failure on hemodialysis, and anticoagulation therapy. Sheath size was removed on step 2, anticoagulation therapy was removed on step 3, hemoglobin was removed on step 4, male sex was removed on step 5, chronic renal failure on hemodialysis was removed on step 6, age was removed on step 7, and hemoglobin was entered on step 8.
tients.
The reasons for the less bleeding in the protamine group should be discussed. The major reason should be the normalization of local clotting function by protamine, 24) which would affect formation of hematoma. Another reason might be blood leakage from the puncture site in the femoral artery, which would be closely associated with the indwelling arterial sheath. Since immediate sheath removal would be difficult without protamine, there would be a greater risk of blood leakage in the nonprotamine strategy.
Study limitations:
The present study has the following limitations. First, since this study was a retrospective single center study, there may be patient selection bias. Second, we could not include the actual time of manual compression because we did not record it in our catheterization laboratory notes. Also, since the study population was relatively small, the statistical analysis has an inherent risk of beta error. 25) Because total number of patients with bleeding requiring blood transfusion was only four, the efficacy of protamine for prevention of blood transfusion should be investigated in future prospective studies. We excluded emergent PCI that was performed to the culprit of acute coronary syndrome (ACS) because we considered that protamine should not be routinely used for the culprit of ACS especially in Japan, where GP IIb/IIIa inhibitors were not available. Furthermore, the activation of P2Y12 inhibitors such as clopidogrel or ticlopidine would not be enough when emergent PCI to the culprit of ACS was just finished. The protamine strategy might be applicable for the culprit of ACS when new generation P2Y12 inhibitors such as prasugrel are more widely used.
26)
Conclusions
The use of protamine for manual compression following elective transfemoral PCI was safe and was associated with less bleeding complications. Future prospective studies to confirm the safety and advantages of protamine following PCI are warranted.
